Immuron Ltd Share Price Today: Live Updates & Key Insights

Immuron Ltd share price today is $0.7031, up -0.85%. The stock opened at $0.71 against the previous close of $0.709, with an intraday high of $0.71 and low of $0.71.

Immuron Ltd Share Price Chart

Immuron Ltd

us-stock
To Invest in {{usstockname}}
us-stock

Immuron Ltd Share Price Performance

$0.7031 -0.0085(-0.85%) IMRN at 23 Mar 2026 01:39 PM Biotechnology
Lowest Today 0.71
Highest Today 0.71
Today’s Open 0.71
Prev. Close 0.709
52 Week High 2.39
52 Week Low 0.68
Day’s Range: Low 0.71 High 0.71
52-Week Range: Low 0.68 High 2.39
1 day return -
1 Week return -
1 month return -7.03
3 month return -20.4
6 month return -61.63
1 year return -63.37
3 year return -63.74
5 year return -89.12
10 year return -

Immuron Ltd Institutional Holdings

Citadel Advisors Llc 0.56

Jane Street Group LLC 0.28

Morgan Stanley - Brokerage Accounts 0.22

XTX Topco Ltd 0.22

BNP Paribas Arbitrage, SA 0.06

Rhumbline Advisers 0.06

UBS Group AG 0.02

SBI Securities Co Ltd 0.00

Immuron Ltd Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Immuron Ltd Fundamentals

Market Cap 7.18 M

PB Ratio 0.6247

PE Ratio 0.0

Enterprise Value 4.26 M

Total Assets 10.09 M

Volume 6117

Immuron Ltd Company Financials

Annual Revenue FY25:7287000 7.3M, FY24:4902865 4.9M, FY23:1804705 1.8M, FY22:765193 0.8M, FY21:145776 0.1M

Annual Profit FY25:4765099 4.8M, FY24:3336797 3.3M, FY23:1309147 1.3M, FY22:523502 0.5M, FY21:94705 0.1M

Annual Net worth FY25:-5215987 -5.2M, FY24:-6936957 -6.9M, FY23:-3786507 -3.8M, FY22:-2591095 -2.6M, FY21:-8398226 -8.4M

Quarterly Revenue Q2/2025:3292660 3.3M, Q1/2025:1646330 1.6M, Q3/2024:2547285 2.5M, Q2/2024:2547285 2.5M, Q4/2023:2355580 2.4M

Quarterly Profit Q2/2025:2108050 2.1M, Q1/2025:1054025 1.1M, Q3/2024:1756449 1.8M, Q2/2024:1756449 1.8M, Q4/2023:1580348 1.6M

Quarterly Net worth Q2/2025:-2764390 -2.8M, Q1/2025:-1363584 -1.4M, Q3/2024:-4863775 -4.9M, Q2/2024:-4863775 -4.9M, Q4/2023:-2073182 -2.1M

About Immuron Ltd & investment objective

Company Information Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. In additon, the company develops IMM-986, that is in pre-clinical stage. Further, it offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

Organisation Biotechnology

Employees 7

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Immuron Ltd FAQs

What is the share price of Immuron Ltd today?

The current share price of Immuron Ltd is $0.7031.

Can I buy Immuron Ltd shares in India?

Yes, Indian investors can buy Immuron Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy Immuron Ltd shares in India?

You can easily invest in Immuron Ltd shares from India by:

Can I buy fractional shares of Immuron Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Immuron Ltd?

Immuron Ltd has a market cap of $7.18 M.

In which sector does Immuron Ltd belong?

Immuron Ltd operates in the Biotechnology sector.

What documents are required to invest in Immuron Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of Immuron Ltd?

The PE ratio of Immuron Ltd is N/A and the PB ratio is 0.62.